Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Glendenning

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Medical Device Technology|July 25, 2009
Developments in multicavity hot runner toolingP Glendenning
Internal Medicine Journal|December 6, 2003
Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelinesP Glendenning
Internal Medicine Journal|March 12, 2002
Inappropriate thyroid-stimulating hormone secretionP Glendenning
Internal Medicine Journal|January 11, 2002
Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceP Glendenning, S D Vasikaran
Internal Medicine Journal|October 11, 2012
What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?P Glendenning, R L Prince
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 1, 2010
Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009S Lee, P Glendenning, C A Inderjeeth
The New England Journal of Medicine|April 1, 2000
Treatment of primary hyperparathyroidismP Glendenning, D H Gutteridge, R W Retallack
The Medical Journal of Australia|February 24, 2001
Pituitary apoplexy: the importance of citing the differential diagnosisP Glendenning, P T Pullan, N W Knuckey
Clinical Endocrinology|May 29, 2010
Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failureN Boudville, C Inderjeeth, G J Elder, et al.
Archives of Biochemistry and Biophysics|July 20, 2000
Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cellsP Glendenning, T Ratajczak, I M Dick, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Medical Device Technology|July 25, 2009
Developments in multicavity hot runner toolingP Glendenning
Internal Medicine Journal|December 6, 2003
Diagnosis of primary hyperparathyroidism: controversies, practical issues and the need for Australian guidelinesP Glendenning
Internal Medicine Journal|March 12, 2002
Inappropriate thyroid-stimulating hormone secretionP Glendenning
Internal Medicine Journal|January 11, 2002
Bone markers in patients with multiple myeloma and monoclonal gammopathy of undetermined significanceP Glendenning, S D Vasikaran
Internal Medicine Journal|October 11, 2012
What is the therapeutic target level of 25-hydroxyvitamin D in osteoporosis and how accurately can we measure it?P Glendenning, R L Prince
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 1, 2010
Efficacy, side effects and route of administration are more important than frequency of dosing of anti-osteoporosis treatments in determining patient adherence: a critical review of published articles from 1970 to 2009S Lee, P Glendenning, C A Inderjeeth
The New England Journal of Medicine|April 1, 2000
Treatment of primary hyperparathyroidismP Glendenning, D H Gutteridge, R W Retallack
The Medical Journal of Australia|February 24, 2001
Pituitary apoplexy: the importance of citing the differential diagnosisP Glendenning, P T Pullan, N W Knuckey
Clinical Endocrinology|May 29, 2010
Association between 25-hydroxyvitamin D, somatic muscle weakness and falls risk in end-stage renal failureN Boudville, C Inderjeeth, G J Elder, et al.
Archives of Biochemistry and Biophysics|July 20, 2000
Calcitriol upregulates expression and activity of the 1b isoform of the plasma membrane calcium pump in immortalized distal kidney tubular cellsP Glendenning, T Ratajczak, I M Dick, et al.
Pageof 2